AKBA icon

Akebia Therapeutics
AKBA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$4.67
231% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Julian Harrison
33% 1-yr AKBA win rate
25 Feb ‘26 1 month ago
Piper Sandler
Piper Sandler
Allison Bratzel
100% 1-yr AKBA win rate
6 Feb ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
25% 1-yr AKBA win rate
6 Feb ‘26 2 months ago